Abstract Adult neurogenesis, the production of mature neurons from progenitor cells in the adult mammalian brain, is linked to the etiology of neurodegenerative and psychiatric disorders. However, a thorough understanding of the molecular elements at the base of adult neurogenesis remains elusive. Here, we provide evidence for a previously undescribed function of fibroblast growth factor 14 (FGF14), a brain diseaseassociated factor that controls neuronal excitability and synaptic plasticity, in regulating adult neurogenesis in the dentate gyrus (DG). We found that FGF14 is dynamically expressed in restricted subtypes of sex determining region Y-box 2 (Sox2)-positive and doublecortin (DCX)-positive neural progenitors in the DG. Bromodeoxyuridine (BrdU) incorporation studies and confocal imaging revealed that genetic deletion of Fgf14 in Fgf14 −/− mice leads to a significant change in the proportion of proliferating and immature and mature newly born adult granule cells. This results in an increase in the late immature and early mature population of DCX and calretinin (CR)-positive neurons. Electrophysiological extracellular field recordings showed reduced minimal threshold response and impaired paired-pulse facilitation at the perforant path to DG inputs in Fgf14 −/− compared to Fgf14 +/+ mice, supporting disrupted synaptic connectivity as a correlative read-out to impaired neurogenesis. These new insights into the biology of FGF14 in neurogenesis shed light into the signaling pathways associated with disrupted functions in complex brain diseases.
Introduction
Adult neurogenesis in the central nervous system is a dynamic multistage process that includes proliferation, differentiation, migration, maturation, and functional integration of newborn neurons in the adult brain circuitry [1, 2] . This process has recently gained significant attention as a potential cause Electronic supplementary material The online version of this article (doi:10.1007/s12035-015-9568-5) contains supplementary material, which is available to authorized users.
underlying cognitive pathophysiology in the context of neurological and psychiatric disorders such as Alzheimer's disease, Parkinson's disease, depression, anxiety, schizophrenia, and bipolar disorder [3] [4] [5] [6] [7] [8] [9] . While observed in several regions of the adult brain, it is adult neurogenesis in the subgranular zone (SGZ) of the dentate gyrus (DG) within the hippocampal formation to which critical roles for memory formation and cognitive function have been ascribed [3, 4, [10] [11] [12] . The steady replenishment of DG granule neurons with a pool of newly born cells throughout adult life is required for the maintenance of hippocampal neuronal plasticity, learning and memory, and ultimately complex cognitive function [3, 11, 13] . Interference with adult neurogenesis processes is considered a hallmark of neurodegenerative and psychiatric disorders [7, [14] [15] [16] . Yet, despite the emerging interest for adult neurogenesis in the neuroscience field, a complete understanding of the signaling pathways that control each given step of this process remains elusive. Finding new molecular targets underlying adult neurogenesis might improve our understanding of complex brain disorders and provide guidance for new treatment development or biomarker identification.
Abundant evidence indicates that secreted fibroblast growth factors (FGF), such as FGF2 through its FGF tyrosine kinase receptor pathway, are essential for neuronal development and neurogenesis [17] [18] [19] [20] . Furthermore, because the Fgfr1 gene promotes the proliferation of hippocampal progenitors and stem cells during development, conditional deletion of this gene causes a decrease in proliferating radial glial cells in the hippocampal DG in the late embryonic period through adulthood [19, 21] . Whether other members of the same gene family have a role in this process has not yet been investigated [22] .
The intracellular FGF (iFGF) group includes FGF11-14, factors that share sequence and structure homology with secreted FGFs but are not secreted and do not act through tyrosine kinase receptor activation. Instead, iFGFs are retained intracellularly and expressed primarily in neurons [23] . Among iFGFs, FGF14 is abundantly expressed in the cerebellum, hippocampus, and neocortex of the adult and developing brain [24] [25] [26] . In central neurons, FGF14 serves as an accessory-regulatory protein of the voltage-gated sodium channels, as a scaffold for kinases [27] [28] [29] [30] [31] [32] , and possibly a presynaptic organizer at excitatory synapses [33] . In animal models, genetic deletions and/or dominant negative mutations of Fgf14 lead to cerebellar deficits and impaired hippocampal synaptic plasticity, neural excitability, and cognitive function [24, 34] .
In humans, missense, non-sense, and frameshift mutations along with chromosome translocations and deletion of FGF14 [35] [36] [37] [38] are genetic causes of spinocerebellar ataxia type 27 (SCA27) [39] , an autosomal dominant neurodegenerative disease characterized by complex motor and cognitive components [26, 40, 41] . Clinical profiling of SCA27 patients is partially recapitulated by the Fgf14 −/− mouse model [42] , suggesting loss-of-FGF14 function as a disease component. Recent studies provide additional evidence of FGF14 as a disease relevant gene: several genome-wide association studies (GWASs) reported single nucleotide polymorphisms (SNPs) in FGF14 as a putative risk factor for schizophrenia, bipolar disorder, and depression, increasing interest in this molecule for a wider range of brain disorders [26, 28, 29, 32, [41] [42] [43] [44] [45] [46] ]. Yet, a comprehensive model of FGF14 mechanisms of action in the brain is far from complete. Based on structural and sequence homology of iFGFs, with their cognate canonical FGF [29, [47] [48] [49] abundantly implicated in adult neurogenesis [50] , and the phenotypic array of deficits observed in Fgf14 −/− mice, we hypothesized a role of FGF14 in adult neurogenesis. Through a combination of confocal imaging, bromodeoxyuridine (BrdU) labeling, and electrophysiology, we identify a previously unreported role of FGF14 in neurogenesis. Our results show that genetic deletion of Fgf14 disrupts neurogenesis, reducing the number of proliferating cells and impairing the transition of newly born adult neurons from the late immature to the mature, with implications for DG synaptic connectivity and short-term plasticity. These results shed light into the biology of complex brain disorders associated with FGF14 in which disrupted neurogenesis is a known component of the disease.
Material and Methods

Animals
Fgf14
−/− and Fgf14 +/+ male and female mice are maintained on an inbred C57/BL6J background with greater than ten generations of backcrossing to C57/BL6J. Animals were bred in the UTMB animal care facility: either heterozygous Fgf14 +/− males and females or, in few cases, homozygotes Fgf14 −/− males with Fgf14 +/− females; Fgf14 +/+ wild-type mice served as control. Both male and female mice were used in this study at 4-6 months of age, unless otherwise stated. The University of Texas Medical Branch operates in compliance with the United States Department of Agriculture Animal Welfare Act, the Guide for the Care and Use of Laboratory Animals, and IACUC approved protocols. Mice were housed, n ≤ 5 per cage, and kept under a 12-h light/12-h dark cycle with sterile food and water ad libitum. All genotypes described were confirmed by genotyping of the progeny using DNA extraction and PCR amplification following established protocols [26] or conducted at Transnetyx Inc. (Cordova, TN). Both male and female animals were used in this study.
BrdU Injections
For the analysis of neural stem cell proliferation and survival, animals received a daily injection of 50 mg/kg thymidine analog BrdU intraperitoneally freshly prepared (SigmaAldrich, St. Louis, MO) at a concentration of 10 mg/ml dissolved in a sterile 0.9 % NaCl solution for 4 or 5 days; animals were examined 5, 15, and 30 days (see Figs. 3i and 6b, c, g for a schematic diagram of injections).
Paraformaldehyde Fixation
Age-and gender-matched Fgf14 +/+ and Fgf14 −/− mice were first deeply anesthetized with 2,2,2-tribromoethanol (250 mg/ kg i.p.; Sigma-Aldrich, Saint Louis, MO) and then perfused intracardially with 1 X phosphate-buffered saline (PBS), followed by 1 % formaldehyde (available commercially from MasterTech Scientific, Lodi, CA) or 4 % paraformaldehyde (Sigma-Aldrich) solution freshly prepared. To ensure complete tissue fixation, the brains were removed carefully and transferred into either 1 % formaldehyde for 30 min to 1 h or 4 % paraformaldehyde 24-48 h at 4°C and then cryopreserved in 20-30 % sucrose/PBS in preparation for sectioning.
Volumetric and Morphometric Analyses
Cresyl violet (Nissl) staining was performed to conduct DG volumetric analysis in age-and gender-matched Fgf14 
Immunofluorescence of Brain Sections
The immunohistochemistry protocol used for this study was slightly modified from previous reports [32] . Briefly, brains were sectioned sagittally into 20-25 μm slices using a Leica CM1850 cryostat (Leica Microsystems, Buffalo Grove, IL) and slices stored in a cryoprotectant solution at −20°C. Free floating or glass slide-mounted sections were washed with 1 X PBS and 1 X Tris-buffered saline (TBS), respectively, then pre-incubated with a permeabilizing agent (1 % Triton X-100, 0.5 % Tween 20 in 1 X PBS or acetone for 7-10 min). For BrdU labeling, sections were treated with 1 N HCL for 10 min followed by 2 N HCl for 10 min at room temperature then 20 min at 37°C. Then, slices were incubated with borate for pH correction: 0.1 M borate buffer pH 8.5 for 10 min at room temperature. Free floating or glass slide-mounted sections were again washed with 1 X PBS and 1 X TBS, respectively, incubated for 7 min for permeabilization, and then washed five times with 1 X PBS. Sections were then incubated with a blocking buffer (10 % normal goat serum (NGS)) (Sigma-Aldrich) or 3-5 % donkey serum (Santa Cruz Biotechnology, Dallas, TX) in 1 X TBS containing 0.3 % Triton X-100 for 1 h. Finally, sections were incubated overnight at 4°C on an orbital rotator with primary antibodies in 3 % bovine serum albumin (BSA) (Sigma-Aldrich) in 1 X PBS containing 0. 
Data Acquisition and Image Analysis
All confocal images were analyzed using ImageJ US NIH (http://imagej.nih.gov/ij). For FGF14 subcellular localization analysis, a single confocal image slice from each Z-stack was chosen for pixel intensity quantification based on the highest fluorescence intensity for given analytes (i.e., DCX ± Sox2; DCX ± NeuN). For soma expression level, a region of interest (ROI) corresponding to a line of 3 pixels in width and variable length was highlighted across the cell soma on the overlay image of FGF14, Sox2, and DCX or FGF14, DCX, and NeuN staining. For Sox2 soma size and fluorescence intensity analysis, Z-stacks of confocal images were sum-projected and an ROI corresponding to soma was highlighted using an intensity threshold method and quantified. Type I and type II Sox2 + /nestin + cells were sorted with the integrated Cell Counter plugin for ImageJ (cell_counter.jar) as described in [51] ; type I cells correspond to nestin + and Sox2 + radial glialike processes, while type II corresponds to non-radial labeled nestin + and Sox2 + cells. DCX + cells were identified and counted from Z-stacks of confocal images of DCX immunostaining using the Cell Counter plugin and confirmed by an automated fluorescence intensity threshold-based cell counter macros developed in house. Soma size and fluorescence intensity of DCX were obtained from a selection of the three DCX + cells with the largest soma as described in [52] . Analysis of migration of DCX + cells was conducted from Zstacks of confocal images of DCX + cells stained with the nuclear marker Topro-3; layers within the DG (SGZ, GCL, and ML) were defined as described in [52] . All other cell counting, soma size and fluorescence intensity analyses conducted in calretinin, calbindin, BrdU, and caspase 3-positive cells were conducted as described above for DCX.
Electrophysiological Recordings
Age-matched mice (2-3 months, N = 4 per group, n = 18-21 independent experiments) were anesthetized with 2,2,2-tribromoethanol (250 mg/kg i.p.; Sigma-Aldrich, Saint Louis, MO) and intracardially perfused with an ice-cold sucrose-based artificial CSF solution containing, in millimolar, 56 NaCl, 100 sucrose, 2.5 KCl, 20 glucose, 5 MgCl 2 , 1 CaCl 2 , 30 NaHCO 3 , 1.25 NaH 2 PO 4 , and 1 kynurenic acid. Following decapitation, horizontal hippocampal slices (300 μm) were cut with a vibratome VT1200S (Leica, Buffalo Grove, IL) in the sucrose-based artificial CSF solution and transferred to a recovery chamber with 95 % O 2 and 5 % CO 2 bubbled regular artificial CSF (containing in mM, 125 NaCl, 2.5 KCl, 2 MgCl 2 , 2.5 CaCl 2 , 1.25 NaH 2 PO 4 , 26 NaHCO 3 , and 20 glucose) at room temperature. After at least 90 min of recovery, recordings were performed in regular artificial CSF in a submerged chamber with addition of GABAergic blocker, bicuculline (10 μM), at 31-32°C. Recordings of field excitatory post-synaptic potentials (fEPSPs) were performed in the granular cell layer of the hippocampal DG with a tungsten electrode placed in an upper blade of dentate gyrus and connected to an A-M Model 1800 Differential AC Amplifier (A-M Systems, Carlsborg, WA). Perforant path fibers were stimulated by a bipolar tungsten electrode, with 0.1-ms pulses of constant current. The traces were digitized by a Digidata 1200 interface using Clampex 7, and the slopes of the fEPSPs were measured offline with Clampfit 9.0 (PClamp software; Molecular Devices, Union City, CA).
Statistical Analysis
Data were expressed as mean ± standard error of the mean (SEM), and the statistical significance of observed differences among groups was determined by two-sample Student's t test or the corresponding nonparametric test, Mann-Whitney rank sum test, based on the distribution of the samples underlying the populations. A P < 0.05 was regarded as statistically significant. Statistical analysis was performed with SigmaPlot 12 and tabulated with Microsoft Excel.
Results
Expression Profile of FGF14 During Adult Hippocampal Neural Stem Cell Development
To begin exploring the role of FGF14 in adult hippocampal neurogenesis, we examined FGF14 expression pattern in the DG along with neurogenesis markers. In adult mice, FGF14 immunoreactivity exhibits a specific expression pattern at the axonal initial segment (AIS) of mature neurons (identified by NeuN and calbindin expression) within the granule cell layer where it co-localizes with the AIS resident protein, ankyrin-G (Fig. 1a-c , g upper set and h; note the absence of FGF14 staining in Fgf14 −/− mice Fig. 1d -f, g lower set). We then (Fig. S1N ), or DCX − /NeuN + , where FGF14 expression instead was more pronounced in the AIS (Fig. S1P) . In calbindin + mature neurons, FGF14 soma expression decreases and becomes almost restricted to the AIS (Fig. 1g, h ). Thus, FGF14 expression is dynamically regulated, switching from a somatic to axonal pattern in late immature to mature neural progenitor transition (Fig. 2) .
The Effect of FGF14 Genetic Deletion on the Neural Stem Cell Population
Given the FGF14 specialized expression pattern in distinct newly born neurons subtypes, we posited that deletion of the FGF14 gene might have an impact on neurogenesis. Through multi-channel confocal imaging in Fgf14 −/− and Fgf14
+/+ mice, we first analyzed the population of Sox2 + cells and found that neither the total number of Sox2 + cells (P = 1, Student's t test; Fig. 3a, c) nor their basic morphological characteristics (i.e., soma size) (P = 0.8, Mann-Whitney test; Fig. 3a, b) were affected upon deletion of Fgf14. Though, we did observe a slight reduction in the Sox2 protein content per cell in Fgf14 −/− compared to Fgf14 +/+ mice (95.9 ± 1.3 %, 100 ± 1.5 %, P = 0.04, Mann-Whitney test; Fig. 3b ). Under physiological conditions, reduction of Sox2 expression correlates with the neural stem cell exiting from the cell cycle and entering a differentiation stage. Thus, deletion of Fgf14 might cause a premature acceleration of early progenitors toward neuronal differentiation [53] . We further investigated whether alterations in temporal dynamics of stem cell development might be restricted to a specific subtype of neuronal stem cells. Neuronal progenitor cells can be morphologically classified into type I and type II based on the presence or absence of radial processes, respectively [51, 53] (Fig. 3d,  e) . Quantification based on the combination of Sox2 and nestin immunoreactivity led to the conclusion that neither type I nor type II cells were largely affected by deletion of Fgf14 (Fig. 3d, g ), albeit a small non-statistically significant reduction in Sox2 + /nestin + type II cell number was detected in Fgf14 −/− mice compared to controls (P = 0.06, Student's t test; Fig. 3f ). Other analysis indicated no reduction in the number of type IIb cells [54] in Fgf14 −/− mice compared to controls (P = 0.5, Student's t test; Fig. S2A , B). These immunolabeling experiments allowed estimation of the total number of cells within a given cell type population at a steady-state level but did not provide information on the actual role of FGF14 in the neurogenesis process. To directly examine whether FGF14 had any significant role in early stages of neurogenesis, we performed BrdU pulse-chase experiments labeling cells 5 days after injection, a commonly used protocol to track putative stem cells and progenitors in the proliferative and early differentiation phases (type IIa, type IIb, and type III cells). Our analysis revealed a significant reduction in BrdU + cells in Fgf14 −/− mice compared to controls (51.1 ± 11.5 %, 100 ± 13.7 %, P < 0.02, Student's t test; Fig. 3h, i) .
Ablation of Fgf14 Increases the Number of DCX-Positive Immature Neurons
Given that no changes were found in any Sox2 + cells in Fgf14 −/− mice, we posited that FGF14 deletion might affect the pool of early differentiated neurons (type III) that have just lost Sox2 and nestin marker expression and begin to differentiate. To test this hypothesis, we examined the expression level and pattern of DCX, a microtubule binding protein that regulates neuronal migration in pre-and postnatal development, as a marker of neuronal progenitors and early immature neurons [55, 56] . Notably, we observed that the DCX + cell number was remarkably increased in Fgf14 −/ − animals compared to Fgf14 +/+ (124.5 ± 7.6 %, 100 ± 7.4 %, P < 0.03, Student's t test; Fig. 4a, b) . Furthermore, the DCX protein content per cell soma was significantly higher in Fgf14 −/− compared to Fgf14 +/+ mice (119 ± 4.9 %, 100 ± 4.9 %, P < 0.006, Mann-Whitney test; Fig. 4e ), despite a comparable soma size in the two genotypes (P = 0.9, MannWhitney test; Fig. 4e ). The distance traveled by DCX + cells across GCL specific sublayers in the two genotypes was comparable, even though in Fgf14 −/− animals DCX + migratory cells tended to accumulate in the middle of the molecular layer (P = 0.07, Student's t test; Fig. 4c, d ).
FGF14 Is Required for Proper Maturation and Integration
We then examined the effect of Fgf14 genetic deletion on newborn neurons at a post-mitotic stage. To this end, we sorted late immature and mature granule neurons using calretinin (CR) and calbindin (CB), respectively [57] (Figs. 5a, b and S3A-D). In Fgf14 −/− animals, CR + cells were significantly more abundant than in control Fgf14 +/+ mice (161.9 ± 13.4 %, 100 ± 9.2 %, P < 0.002, Student's t test; Fig. 5c, d) , and the CR + cell content per soma and the soma size were higher (112.1 ± 3.1 %, 100 ± 3.7 %, P < 0.02, MannWhitney test; 119.1 ± 6.2 %, 100 ± 5.9 %, P < 0.03, Student's t test, respectively; Fig. 5d) . Notably, the mature CB + neuron population was unchanged in Fgf14 −/− animals (P = 0.2, Student's t test), while the CB protein content was reduced in Fgf14 −/− compared to Fgf14 +/+ mice (83.8 ± 0.5 %, 100 ± 0.8 %, P < 0.001, Mann-Whitney test; Fig. 5e, f) .
FGF14 Genetic Deletion Affects the Early Survival Phase of Newborn Neurons
To assess the role of FGF14 in the immature and mature newly born cell population, we injected BrdU once per day for 4 or 5 days and examined cells either 15 or 30 days later, respectively (see scheme in Fig. 6b, c) . Fifteen days after injection, the total BrdU + cell population was reduced dramatically in Fgf14 −/− compared to Fgf14 +/+ mice (69.7 ± 4.3 %, 100 ± 7.6 %, P < 0.007, Student's t test; Fig. 6a, b ) but was comparable in the two experimental groups after the 30-day pulse (P = 0.9, Student's t test; Fig. 6c-e) . Notably, the majority of 30-day treated BrdU + cells were DCX − /NeuN + in Fgf14 +/+ mice (100 ± 11.7 %, 42.8 ± 9.5 %, Student's t test) but DCX + in Fgf14 −/− animals (344 ± 70.7 %, 100 ± 29.1 %, Student's t test; Fig. 6d ). Complementary experiments were performed to determine whether changes in the population of immature and mature newly born neurons could be reconciled with deficits in the apoptotic signaling pathway; BrdU + cells showed no significant difference in somatic active caspase-3 expression between the two genotypes (P = 0.8, MannWhitney test; Fig. 6f, g ). These results indicate that the pool of survived newly born DG neurons in Fgf14 −/− mice might be developmentally arrested at the DCX + late immature stage. We posited that such an aberrant neurogenic process might, over the long term, impact the DG structure and gross anatomy. Using Nissl staining (Fig. 6h) , we conducted a volumetric analysis of the entire DG volume. In accordance with previous studies [26] , we found no gross anatomical alterations in the two experimental groups (P = 0.5 in I, P = 0.9 in K, Student's t test; Fig. 6h-k) . Nor did we find changes in the total population of DG cells as estimated by nuclear staining (data not shown). DG adult neurogenesis plays a critical role in the maintenance of the trisynaptic hippocampal circuitry, a central station for signal processing in the brain. Thus, even subtle changes in DG circuitry cell composition could have broader consequences for the entire brain structure. Consistent with this hypothesis, we found a slight but significant reduction in the weight of Fgf14 −/− compared to Fgf14 +/+ brains (93.1 ± 1.3 %, 100 ± 1.8 %, P < 0.03, Student's t test; Fig. 6l, m) , a feature that often accompanies brain pathologies associated with neurogenesis deficits [58] .
FGF14 Genetic Deletion Results in Aberrant DG Synaptic Activity
We then asked whether the changes in the newly born neuron population observed in Fgf14 −/− animals could affect the DG synaptic circuitry [59, 60] . To this end, we stimulated perforant path to DG inputs and used electrophysiological field recordings to evoke (fEPSPs, Fig. 7a ). We found that the minimal threshold field response was significantly reduced in Fgf14 −/− mice compared to control (133.3 ± 9 μA, N = 4, n = 18 in Fgf14 −/− mice versus 111.9 ± 4.8 μA in control; P < 0.05, Fig. 7c ). Yet, the fEPSP slope was comparable in the two experimental groups for all other given stimuli exceeding minimal stimulation. To study short-term synaptic plasticity, we applied a protocol consisting of paired pulses with inter-pulse intervals (IPI) of variable duration and measured the ratio of pulse 2 to pulse 1 for the fEPSP slope (Fig. 7d, e) . We found that the paired-pulse ratio (PPR) was reduced in the Fgf14 −/− group at 100 ms IPI compared to control values (145.5 ± 3.1 % in Fgf14 −/− mice versus 155.1 ± 3.5 % in control; P < 0.05 with Student's t test; Fig. 7e) . Notably, PPR values that exceeded 100 ms IPI (i.e., 200, 300 ms) were significantly higher in Fgf14 −/− mice compared to control (at 200 ms −127.9 ± 2.7 % in Fgf14 −/− mice versus 118.7 ± 365 % in control; P < 0.05 with Student's t test and at 300 ms −110 ± 2.9 % in Fgf14 −/− mice versus 98.7 ± 3.3 % in control; P < 0.05 with Student's t test; Fig. 7e ).
Together, these results suggest that adult neurogenesis in the DG requires FGF14 expression in newly developing neurons (Fig. 7) to guarantee the transition of late immature to early mature neurons and that disruption of FGF14 function impairs synaptic integration of neurons in the DG circuitry.
Discussion
Adult neurogenesis occurs through distinct stages including proliferation, differentiation, migration, maturation, and integration of newly born neurons. These neurons derive from neural stem cells that steadily integrate into the adult brain circuitry [1, 2] . Disruption of this multistage process has been implicated in complex cognitive functions and emotional responses that are altered in neurodegenerative and neuropsychiatric disorders [3] [4] [5] . In the present study, we have uncovered a novel role for Fgf14, a gene harboring inherited mutations leading to SCA27 and SNPs associated with psychiatric disorders, in adult neurogenesis. Our data demonstrate that FGF14 plays a role in the maturation of adult neural stem cells that may be related to the expression/function of FGF14 during the development of progenitor cells. We found that newly born granule neurons in −/− mice (n = 3 mice, three to four sections per mouse, means across genotypes are non-statistically different). h Confocal images of BrdU, Sox2, and DCX-labeled cells in the dentate gyrus from 6-month-old female Fgf14
+/+ and Fgf14 −/− mice. i Top, experimental design; bottom part, quantification of BrdU + cells in DG after 4 BrdU (50 mg/kg) i.p. injections (n = 2 mice per group, five sections per mouse). Data are mean ± SEM, *P < 0.05, Student's t test. Scale bars represent 50 μm in a, d, and h; 10 μm in e region [32] , yet a postnatal time-course study has been lacking. To gain knowledge on a potential role of FGF14 in neurogenesis, we examined the expression pattern of FGF14 along with selected neurogenesis markers in the adult DG. In accordance with previous studies, FGF14 immunoreactivity in mature neurons (NeuN + ) is high at the AIS. However, at earlier stages, its expression level and pattern vary. Our findings indicate that FGF14 expression is regulated dynamically, consistent with other proteins that are implicated in regulating adult neurogenesis such as Alk5, notch, and TrkB [52, 61, 62] .
Notably, while FGF14 exhibits a more diffused pattern with cell body localization in type IIb cells, it exhibits a distinct, perisomatic cone-like pattern in late progenitors. Though the significance of this expression pattern profile remains to be determined, it may indicate developmentally regulated specialized functions of FGF14 at an early post-mitotic phase in which the newly born neuron's axon is formed and dendritic arborization is built [63] .
Genetic deletion of Fgf14 did not affect the early proliferating neural stem cell pool but caused a significant increase in (Fig. 6d) ; the time by which newly born cells would be fully mature under normal conditions [64] . Together, these phenotypes could signify that the FGF14 wild-type gene/protein suppresses a signaling program to exit mitosis and proceed into full maturation. Disruption of this suppressing signal might produce ineffectual neurons that are in a developmentally arrested stage (DCX + ) and unable to integrate into the hippocampal circuitry at a proper rate. Alternatively, increases in both DCX + and 
CR
+ cells might serve as a compensatory response to a pool of reduced Sox2 + progenitors (Fig. 3h, i) (Fig. 6d) . We have detected a slight but significant reduction in CB content per cell in Fgf14 −/− animals which may indicate (or be a causal effect) of reduced intracellular Ca 2+ buffering capability in mature CB + cells.
In wild-type mice, the population of proliferating BrdU + cells decreases as adult neurogenesis proceeds; only~50 % of proliferating cells survive 1 month after birth [13] . In Fgf14 (Fig. 3a, c) . Furthermore, we found no changes in apoptosis levels in Fgf14 −/− animals. Notably, a small but significant change in Sox2 expression was found in Fgf14 −/− mice.
Decreased Sox2 expression is a biological signal that accompanies the transition from mitosis to differentiation [53] . Thus, reduction in FGF14 expression might result in a persistent mitotic exit signal, accelerating the transition of type II into type III newly born neurons. In the long-term, loss of FGF14 function might cause structural and functional changes that lead to slow DG circuitry deterioration with influence on other brain areas. Accordingly, Fgf14 −/− mice exhibit a significant reduction in the whole brain weight that might result from loss of neurons.
In agreement with impaired neurogenesis, we detected functional changes in the DG circuit of Fgf14 −/− animals.
Upon stimulation of the perforant pathway, the major extrahippocampal input to DG granule cells, we observed a reduced minimal threshold response of fEPSPs, and bidirectional changes in paired-pulse facilitation, in Fgf14 −/− compared to Fgf14 +/+ animals. In addition, PPF was lower in Fgf14 −/− versus Fgf14 +/+ at 100 ms but higher for longer inter-pulse intervals. The alterations in time-dependent facilitation observed in Fgf14 −/− animals are consistent with synaptic input remodeling of the DG circuit, such as granule cell axonal sprouting, homeostatic changes driven by GABAergic inputs or modifications of the release machinery, and excitatory presynaptic terminals [65, 66] . These phenotypes suggest that altered neurogenesis might lead to an over-excitable DG circuit, more prone to an epileptic-like status, or locked in an immature stage [66] [67] [68] . Future studies are required to confirm this hypothesis. FGF14 is an integral component of the AIS, a regulator of neuronal excitability, an organizer of the presynaptic release machinery, a scaffold for signaling pathways downstream of tyrosine kinase receptors [24, 28, 30-32, 33, 41, 46, 69-73] , and a regulator of synaptic plasticity [26, 74] . In Fgf14 −/− animals, some or all of these functions may be disrupted resulting in aberrant adult neurogenesis. The phenotypes reported in this study might result from cell-autonomous mechanisms that are ascribed to cell-specific and time-dependent expression of FGF14 in the population of developing neurons. For instance, lack of the FGF14 protein in early stages of neurogenesis in immature Sox + cells that are electrically inactive might be associated with disrupted signaling pathways. In regard to the signaling pathways, FGF14 may trigger downstream mechanisms common to other FGFs. Our and previous studies implicate FGF14 in neuronal development and neurogenesis, which are well-known phenotypes controlled by canonical FGF signaling [17] . Though the endpoint of regulating neurogenesis may be different in canonical versus iFGF, for members of the same family, our data support functional conservation beyond that of transmembrane signaling, which may be part of a global cell program required for organ development. Another signaling pathway classically linked to adult neurogenesis is DISC1, a multifaceted, intracellular scaffolding protein operating through a large macromolecular signaling complex [1, 14, [75] [76] [77] . One of the DISC1 partners shown to be important for proper neuronal maturation is GSK3β [14, 78] . Previous studies reported FGF14 as a new target of the GSK3 signaling pathway [32] , which may be an indirect pathway by which FGF14 affects adult neurogenesis.
In electrically active DCX + and CR + neurons [13] , lack of the FGF14 protein might have a more prominent effect on neuronal firing, disrupting Nav channel targeting to the AIS, impairing neuronal excitability and impeding or delaying the establishment of neuronal polarity [28, 32] . In addition, or as an alternative, to cell-autonomous activity, loss of Fgf14 may act globally and adversely influence neuronal activity of the entire DG. This would result in a microenvironment that prevents proper maturation and integration of newly born cells in the synaptic circuitry [79] [80] [81] [82] . − cell number in the DG of both genotypes (n = 3 mice per group, four to seven sections per mouse, **P < 0.01,***P < 0.001, Student's t test). f Immunohistochemical detection of caspase 3 activity in BrdU + cells at low (top) and high power (bottom) in the DG from 6-to 7-month-old Fgf14 +/+ and Fgf14 −/ − mice. g Top, schematic representation of study design; bottom, quantification of caspase 3 fluorescence intensity within BrdU + cells from 6-to 7-month-old Fgf14 +/+ and Fgf14 −/− mice (n = 3 mice per group, three to four sections per mouse, mean is non-statistically different). h, j Cresyl violet (Nissl) staining derived from sagittal brain sections (4-5 months old) revealed normal patterns of gross anatomy in Fgf14 −/− mice compared to Fgf14 +/+ at low (h, i) and a higher magnification of the upper DG blade (j, k) (n = 1-2 slices/mouse and seven mice littermates gender-matched). l Representative brain weight from 6-to 7-month-old Fgf14 +/+ and Fgf14 −/− mice. m Quantification of brain weights of Fgf14 +/+ and Fgf14 −/− mice (n = 4 mice per group, *P < 0.05, Student's t test). Data are presented as mean ± SEM. Scale bars represent 100 μm in a, 50 μm in c and j, 40 μm in f, and 200 μm in h Overall, the phenotypes presented here can be reconciled with immature DG (iDG), with elevation in immature neuronal markers and reduction in mature markers [8, 83, 84] . Several animal models of psychiatric disorders including α-CaMKII heterozygous mice, SNAP-25 knock-in, Schnurri-2 knockout, and region-specific calcineurin knockout mice [83] exhibit iDG phenotypes associated with cognitive impairment similar to those observed in Fgf14 −/− mice in the current and previous studies [8, 26, 74] . In schizophrenic and bipolar disease patients, cellular and molecular phenotypes of iDG have been reported using immunohistochemistry and gene expression profiling, leading to the premise of iDG traits as an endophenotype of brain disorders [8, 83, 84] . Thus, Fgf14 is likely part of a network of risk genes for mental diseases that manifest through deficits in adult neurogenesis. Future investigations on the expression levels of FGF14 in human samples will add translational validity to this Fgf14 −/− model and feasibility of targeting FGF14 for development of more effective therapeutics against mental disorders. Future studies will determine whether pathway convergence of these genes contributes to the broad array of cognitive and emotional impairments associated with human neurological and psychiatric disorders.
Conclusions
We have uncovered a novel role for FGF14 in the transition of neuronal progenitors from a late immature to a mature stage in the adult hippocampus. These results contribute to a deeper understanding of the cellular pathways required for neurogenesis and provide new target genes for therapeutic interventions in rare disorders (i.e., SCA27) and complex diseases associated with SNPs in the FGF14 gene, such as schizophrenia, bipolar disease, and depression.
